Literature DB >> 21997774

Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000-2009.

H-C Hsiue1, T-H Wu, T-C Chang, Y-C Hsiue, Y-T Huang, P-I Lee, P-R Hsueh.   

Abstract

We reviewed 776 patients who were culture positive for Aspergillus species at the hospital from 2000 to 2009. The isolates were collected for species identification by oligonucleotide hybridization and sequence analysis. A total of 96 cases of proven or probable IA were identified according to published criteria. The incidence of IA has increased significantly during the study period. Aspergillus fumigatus and A. flavus (41.7% each) were equally prevalent causative species. IA due to unusual species including A. nidulans (n=2), A. versicolor (n=2), and A. tubingensis (n=1) were also found. Among patients with IA, 55.2% had hematological disorder, 19.8% had underlying lung disorder, and 10.4% had autoimmune disease. The isolates species (P<0.001) and underlying disease (P<0.001) significantly affect the association of a positive culture with invasive disease. The overall mortality at three months was 62.5%, which remained stable throughout the study period. Multivariate analysis identified prior steroid use (P=0.007) as a significant risk factor for death, while surgery (P=0.030) and voriconazole (P=0.012) had protective effects. In conclusion, autoimmune disorders and underlying pulmonary diseases should also be considered as important predisposing factors of IA. Further emphasis on surgery and voriconazole in the management of IA might be beneficial.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21997774     DOI: 10.1007/s10096-011-1445-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.

Authors:  D Neofytos; J A Fishman; D Horn; E Anaissie; C-H Chang; A Olyaei; M Pfaller; W J Steinbach; K M Webster; K A Marr
Journal:  Transpl Infect Dis       Date:  2010-01-25       Impact factor: 2.228

Review 2.  Pediatric aspergillosis: disease and treatment differences in children.

Authors:  William J Steinbach
Journal:  Pediatr Infect Dis J       Date:  2005-04       Impact factor: 2.129

3.  The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.

Authors:  J R Perfect; G M Cox; J Y Lee; C A Kauffman; L de Repentigny; S W Chapman; V A Morrison; P Pappas; J W Hiemenz; D A Stevens
Journal:  Clin Infect Dis       Date:  2001-10-22       Impact factor: 9.079

4.  Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.

Authors:  Po-Ren Hsueh; Yeu-Jun Lau; Yin-Ching Chuang; Jen-Hsien Wan; Wen-Kuei Huang; Jainn-Ming Shyr; Jing-Jou Yan; Kwok-Woon Yu; Jiunn-Jong Wu; Wen-Chien Ko; Yi-Chueh Yang; Yung-Ching Liu; Lee-Jene Teng; Cheng-Yi Liu; Kwen-Tay Luh
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

5.  Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications.

Authors:  Marisa H Miceli; Monica L Grazziutti; Gail Woods; Weizhi Zhao; Mehmet H Kocoglu; Bart Barlogie; Elias Anaissie
Journal:  Clin Infect Dis       Date:  2008-05-01       Impact factor: 9.079

6.  Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions.

Authors:  Shiang Ning Leaw; Hsien Chang Chang; Hsiao Fang Sun; Richard Barton; Jean-Philippe Bouchara; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

7.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 8.  Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease.

Authors:  P Bulpa; A Dive; Y Sibille
Journal:  Eur Respir J       Date:  2007-10       Impact factor: 16.671

9.  Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

Authors:  D Neofytos; D Horn; E Anaissie; W Steinbach; A Olyaei; J Fishman; M Pfaller; C Chang; K Webster; K Marr
Journal:  Clin Infect Dis       Date:  2009-02-01       Impact factor: 9.079

10.  Invasive pulmonary aspergillosis: role of early diagnosis and surgical treatment in patients with acute leukemia.

Authors:  Ridvan Ali; Fahir Ozkalemkas; Tulay Ozcelik; Vildan Ozkocaman; Atilla Ozkan; Sami Bayram; Beyza Ener; Ahmet Ursavas; Guze Ozal; Ahmet Tunali
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-07-27       Impact factor: 3.944

View more
  4 in total

1.  Identification and susceptibility of Aspergillus section nigri in china: prevalence of species and paradoxical growth in response to echinocandins.

Authors:  Yali Li; Zhe Wan; Wei Liu; Ruoyu Li
Journal:  J Clin Microbiol       Date:  2014-12-10       Impact factor: 5.948

2.  Differential Kinetics of Aspergillus nidulans and Aspergillus fumigatus Phagocytosis.

Authors:  Mark S Gresnigt; Katharina L Becker; Floris Leenders; M Fernanda Alonso; Xiaowen Wang; Jacques F Meis; Judith M Bain; Lars P Erwig; Frank L van de Veerdonk
Journal:  J Innate Immun       Date:  2017-12-16       Impact factor: 7.349

3.  Galactomannan Testing and the Incidence of Invasive Pulmonary Aspergillosis: A 10-Year Nationwide Population-Based Study in Taiwan.

Authors:  Kuo-Shao Sun; Ching-Fang Tsai; Solomon Chih-Cheng Chen; Yih-Yuan Chen; Wan-Chun Huang
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

4.  Clinical outcome and prognostic factors associated with invasive pulmonary aspergillosis: An 11-year follow-up report from Taiwan.

Authors:  Kuo-Shao Sun; Ching-Fang Tsai; Solomon Chih-Cheng Chen; Wan-Chun Huang
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.